Parasympathetic dysfunction in hypertrophic cardiomyopathy assessed by heart rate variability: comparison between short‐term and 24‐h measurements

In this study, we evaluate cardiac autonomic function in hypertrophic cardiomyopathy (HCM) by assessing heart rate variability (HRV), comparing a short‐term laboratory method with an ambulatory (24‐h) method, in patients with and without beta‐blockade. Reduced HRV is a risk factor for adverse events in some cardiac diseases, but is not a proven risk indicator in HCM. Analysis of HRV has been based on either short‐ or long‐term electrocardiographic recordings and previous studies in HCM have shown conflicting results. There is no consensus on which method to prefer, and we evaluate, for the first time, both short‐ and long‐term analyses in patients with HCM. Long‐ and short‐term HRV analyses were performed in 43 patients with HCM. They were divided in two groups, 22 patients on beta‐blockade and 21 non‐treated patients. As controls, 121 healthy subjects were used. Young patients without beta‐blockade showed a reduction in HRV parameters reflecting parasympathetic function, both in the short‐ and long‐term registrations, which was attenuated by beta‐blockade. Parasympathetic autonomic regulation was found to be impaired in young patients with HCM. This may be of clinical relevance as abnormal autonomic function might be a substrate for malignant dysrhythmias. The impairment was attenuated by beta‐blockade, which might indicate a clinically useful effect. We also show that short‐ and long‐term methods yield similar results, suggesting that a short‐term registration might be sufficient to assess HRV in patients with HCM.

[1]  H. Inoue,et al.  Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. , 1993, The American journal of cardiology.

[2]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[3]  M Malik,et al.  Short- and long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. , 1996, The American journal of cardiology.

[4]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[5]  A. Balbarini,et al.  Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. , 1998, European heart journal.

[6]  B Lown,et al.  Neural activity and ventricular fibrillation. , 1976, The New England journal of medicine.

[7]  B. N. Gupta,et al.  Behavior of Left Ventricular Mechanoreceptors with Myelinated and Nonmyelinated Afferent Vagal Fibers in Cats , 1983, Circulation research.

[8]  S. Langlois,et al.  Metoprolol withdrawal phenomena: Mechanism and prevention , 1982, Clinical pharmacology and therapeutics.

[9]  A Malliani,et al.  Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. , 1994, The American journal of cardiology.

[10]  Q. Regestein,et al.  Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management. , 1976, The New England journal of medicine.

[11]  M Malik,et al.  Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? , 1995, Journal of the American College of Cardiology.

[12]  R. Liden Reflexes from the heart. , 1975, Progress in cardiovascular diseases.

[13]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[14]  M Pagani,et al.  Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. , 1997, Circulation.

[15]  D. Bonaduce,et al.  Heart rate variability in patients with hypertrophic cardiomyopathy: association with clinical and echocardiographic features. , 1997, American heart journal.

[16]  B. Maron Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[17]  Kinga Howorka,et al.  Functional assessment of heart rate variability: physiological basis and practical applications. , 2002, International journal of cardiology.

[18]  P. Sleight,et al.  Action potentials in afferent fibres from pericardial mechanoreceptors in the dog. , 1965, The Journal of physiology.

[19]  D. Oral,et al.  Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients. , 2001, International journal of cardiology.

[20]  J. Fleiss,et al.  Effect of atenolol and diltiazem on heart period variability in normal persons. , 1991, Journal of the American College of Cardiology.

[21]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[22]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[23]  K. Yoshioka,et al.  Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability. , 1995, European heart journal.

[24]  W J McKenna,et al.  Assessment of Heart Rate Variability in Hypertrophic Cardiomyopathy Association With Clinical and Prognostic Features , 1993, Circulation.

[25]  A. Lammertsma,et al.  Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. , 1993, Journal of the American College of Cardiology.

[26]  R. Page,et al.  Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction. , 1996, The American journal of cardiology.

[27]  A. Burger,et al.  Effect of beta-blockade on heart rate variability in decompensated heart failure. , 2001, International journal of cardiology.

[28]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[29]  O. Schober,et al.  Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. , 1998, Circulation research.

[30]  L. Fauchier,et al.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. , 1997, Journal of the American College of Cardiology.

[31]  D P Zipes,et al.  Influence of Myocardial Ischemia and Infarction on Autonomic Innervation of Heart , 1990, Circulation.

[32]  A. Brandes,et al.  Circadian Profile of Cardiac Autonomic Nervous Modulation in Healthy Subjects: , 2003, Journal of cardiovascular electrophysiology.

[33]  M. Turiel,et al.  Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. , 1995, European heart journal.

[34]  B. Maron,et al.  Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. , 1989, Circulation.

[35]  R. Maestri,et al.  Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.

[36]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[37]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[38]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .